Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Baxter
Harvard Business School
AstraZeneca
Federal Trade Commission
QuintilesIMS
Julphar
Johnson and Johnson
Covington
US Department of Justice

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073536

« Back to Dashboard

NDA 073536 describes PIROXICAM, which is a drug marketed by Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Mylan, Mylan Ireland Ltd, PII, SCS, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs, and is included in nineteen NDAs. It is available from twenty-three suppliers. Additional details are available on the PIROXICAM profile page.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
Summary for 073536
Tradename:PIROXICAM
Applicant:Sun Pharm Industries
Ingredient:piroxicam
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 073536
Medical Subject Heading (MeSH) Categories for 073536
Suppliers and Packaging for NDA: 073536
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PIROXICAM piroxicam CAPSULE;ORAL 073536 ANDA Sun Pharmaceutical Industries, Inc. 57664-657 57664-657-88 100 CAPSULE in 1 BOTTLE (57664-657-88)
PIROXICAM piroxicam CAPSULE;ORAL 073536 ANDA Sun Pharmaceutical Industries, Inc. 57664-658 57664-658-88 100 CAPSULE in 1 BOTTLE (57664-658-88)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Mar 12, 1993TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Jan 23, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Farmers Insurance
Chinese Patent Office
Mallinckrodt
Citi
UBS
Cerilliant
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot